MannKind Corporation ($MNKD) announced an update on their ongoing clinical study. Study Overview: The ICoN-1 Phase 3 study, officially titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback